These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 901057)
1. [Mechanism of action of antiarrhythmic agents]. Méndez R Arch Inst Cardiol Mex; 1977; 47(2):223-32. PubMed ID: 901057 [No Abstract] [Full Text] [Related]
2. [The auricular tissue specialized for conduction: its importance in physiology and antiarrhythmic pharmacotherapy]. Pastelin G; Cuevas B; Alvarado JL; Méndez R Gac Med Mex; 1984; 120(11-12):371-85. PubMed ID: 6152584 [No Abstract] [Full Text] [Related]
3. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366. Baum T; Rowles G; Shropshire AT J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546 [No Abstract] [Full Text] [Related]
4. The pharmacology of Norpace. Dean RR Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403 [No Abstract] [Full Text] [Related]
5. Class III antiarrhythmic action linked with positive inotropy: antiarrhythmic, electrophysiological, and hemodynamic effects of the sea-anemone polypeptide ATX II in the dog heart in situ. Platou ES; Refsum H; Hotvedt R J Cardiovasc Pharmacol; 1986; 8(3):459-65. PubMed ID: 2425158 [TBL] [Abstract][Full Text] [Related]
6. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter]. Jastrzebski M Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102 [TBL] [Abstract][Full Text] [Related]
7. [Antiarrhythmic activity of trimecaine in experimental arrhythmia and its effect on the heart conduction system]. Gendenshteĭn EI; Kostin IaV Farmakol Toksikol; 1976; 39(4):426-8. PubMed ID: 1027568 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter]. López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694 [TBL] [Abstract][Full Text] [Related]
9. [Anti-arrhythmia agents]. Kaufmann G Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645 [No Abstract] [Full Text] [Related]
10. Arrhythmias and antiarrhythmic agents. Heddle WF; Tonkin AM Med J Aust; 1984 Nov; 141(11):715-8. PubMed ID: 6503764 [No Abstract] [Full Text] [Related]
11. [Does vagal hypertonia induced by clonidine modify the atrial refractory period in chloralose-treated dogs?]. Duchêne-Marullaz P; Lavarenne J; Lapalus P; Boucher M; Chassaing C C R Seances Soc Biol Fil; 1972; 166(4):601-4. PubMed ID: 4651593 [No Abstract] [Full Text] [Related]
12. Clinical applications of antiarrhythmic drugs. Lavenne F; de Jonghe D Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012 [No Abstract] [Full Text] [Related]
13. Quinidine like activity of a new central depressant 2-hydroxy-2-phenyl-ethyl carbamate (styramate). Singh KP Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):424-31. PubMed ID: 5868743 [No Abstract] [Full Text] [Related]
14. [Effects of anti-arrhythmia agents on heart rate. Significance and importance]. Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434 [No Abstract] [Full Text] [Related]
15. Antiarrhythmic actions of clemizole as pharmacologic evidence for a circus movement mechanism in atrial flutter. Mendez R; Kabela E; Pastelin G; Martínez-López M; Sánchez-Pérez S Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(3):325-36. PubMed ID: 4388778 [No Abstract] [Full Text] [Related]
16. [Effect of anti-arrhythmia drugs on the heart conduction system]. Walczak F Kardiol Pol; 1992; 36(2):92-6. PubMed ID: 1583832 [No Abstract] [Full Text] [Related]
17. [What is safe in the therapy of tachycardic heart arrhythmias?]. Wehr M; Noll B; Krappe J Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980 [No Abstract] [Full Text] [Related]
18. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062 [TBL] [Abstract][Full Text] [Related]
19. [The antiarrhythmic action mechanism of verapamil (Isoptin)]. Bass O; Friedemann M Schweiz Med Wochenschr; 1971 May; 101(21):792-9. PubMed ID: 5143469 [No Abstract] [Full Text] [Related]